The ticker symbol of Sinopharm is 600511.

GuoYao Group Pharmaceutical Co., Ltd (hereinafter referred to as "the Company" or "the Company") was approved by the People's Republic of China and the State Economic and Trade Commission of the People's Republic of China in the Approval of the Establishment of GuoYao Group Pharmaceutical Co. (State Economic and Trade Commission No. 945) of the People's Republic of China.

The company was established on December 21, 1999 as a joint-stock limited company by China National Pharmaceutical Group Corporation, Guangzhou Nanfang Medical Devices Company, Sinopharm Shanghai Medical Devices Company Limited, Tianjin Qiyu Medical Devices Limited Liability Company, and Beijing Renkang Medical Devices Department***, and was registered by the General Administration for Industry and Commerce of the People's Republic of China.

Sopharmaceuticals:

Sopharmaceuticals Group Pharmaceuticals Co., Ltd. was initiated by China National Pharmaceutical Group Corporation, approved by the State Economic and Trade Commission, was formally established on December 21, 1999, the State Pharmaceuticals Co., Ltd. adheres to the glorious tradition of its predecessor, China National Pharmaceutical Company, for more than half a century, shouldering the sacred mission of preventing and treating diseases of the general public, rehabilitation and health care, first aid for disaster outbreaks, and the central reserve. The company has made unremitting efforts to safeguard the life and health of the public.